Mustafa Nevzat Pharmaceuticals
http://www.mn.com.tr
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mustafa Nevzat Pharmaceuticals
Pharmaceutical Company News from Turkey
PharmAsia News brings you a look at Turkey’s drug market by capturing recent moves by international and domestic firms.
Regulation, Reimbursement Notes From Turkey
A PharmAsia News update shows Turkey has set a target to domestically manufacture 60% of the drug products used annually and 20% of medical device and equipment by an unspecified timeframe. The government also moved to offer more support into R&D for high-value biopharmaceutical products and sent a large ministerial delegation to the annual Bio Conference in San Diego as a signal of how important the sector is to its public health programs.
Regulation, Reimbursements Notes From Turkey
A PharmAsia News update on Turkish biomedical regulatory policies, including reports that the government offered industry to keep discount rates secret and an 11.7% jump in exports in the first four months of 2014.
Regulation, Reimbursement Notes From Turkey
A PharmAsia News update on Turkish biomedical regulatory policies, including a penicillin shortage and an update on a draft patent law.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice